ProfileUpdated on 11 September 2024
Ready to use GMP Cell Banks for Vaccine Production
About
Nuvonis offers fully tested GMP banks of Vero cells and of avian CCX cells that were generated under serum-free conditions. These state-of-the-art banks can be used to immediately move into GMP production for clinical material, thus speeding up your development process. No worries about producing your own cell bank, no uncertainty in timelines, no risk.
Nuvonis offers
- fully characterized GMP compliant cell banks
Nuvonis Key benefits
-
ready-to-use Cell Banks shorten your time to clinical evaluation and time to market by 1-2 years
-
high quality Vero Cell Bank without animal components ensures a safe and efficient production process.
-
novel quail Cell Banks CCX can be used as an alternati9ve to CEF or egg-based production in suspension.
-
save time and money
Language Tag
- English
Industry
- SmartProduction
Product Info
https://nuvonis.com/products/
Organisation
Similar opportunities
Profile
Gebrauchsfertige GMP-Zellbanken für die Impfstoffproduktion.
- German
- SmartProduction
Joachim Seipelt
CBO at Nuvonis Technologies GmbH
Vienna, Austria
Profile
Hydrogen technologies by deploying experience gained with industry and offer high quality since 2005
- Road
- Water
- Safety
- English
- Vehicle
- Railway
- Building
- Mobility
- Efficiency
- Sustainable
- Intelligent
- Aeronautics
- StorageGrids
- SmartProduction
- PersonalFreight
Alexander Trattner
HyCentA Research GmbH – Hydrogen Center Austria Research GmbH
Profile
- English
Andreas Stingl
Phornano Holding GmbH